$RPTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Repare Therapeutics Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Repare Therapeutics Inc.. Get notifications about new insider transactions in Repare Therapeutics Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.51 | 9,943 | 333,190 | 2,278,447 | 2.3 M to 2.3 M (-0.43 %) |
Jun 28 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.53 | 2,697 | 90,430 | 2,288,390 | 2.3 M to 2.3 M (-0.12 %) |
Jun 23 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.98 | 622 | 20,514 | 2,291,087 | 2.3 M to 2.3 M (-0.03 %) |
Jun 23 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.09 | 189 | 6,443 | 2,291,709 | 2.3 M to 2.3 M (-0.01 %) |
Jun 23 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.36 | 1,486 | 49,573 | 2,291,898 | 2.3 M to 2.3 M (-0.06 %) |
Jun 23 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.63 | 14,006 | 485,028 | 2,293,384 | 2.3 M to 2.3 M (-0.61 %) |
Jun 23 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.80 | 2,556 | 86,393 | 2,307,390 | 2.3 M to 2.3 M (-0.11 %) |
Jun 10 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.79 | 10,738 | 373,575 | 2,330,983 | 2.3 M to 2.3 M (-0.46 %) |
Jun 10 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.42 | 4,785 | 164,700 | 2,341,721 | 2.3 M to 2.3 M (-0.20 %) |
Jun 10 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.41 | 7,559 | 252,546 | 2,346,506 | 2.4 M to 2.3 M (-0.32 %) |
Jun 10 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.80 | 3,985 | 130,708 | 2,354,065 | 2.4 M to 2.4 M (-0.17 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.96 | 8,379 | 276,172 | 2,358,050 | 2.4 M to 2.4 M (-0.35 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.96 | 8,379 | 276,172 | 2,358,050 | 2.4 M to 2.4 M (-0.35 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.25 | 749 | 24,155 | 2,366,429 | 2.4 M to 2.4 M (-0.03 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.25 | 749 | 24,155 | 2,366,429 | 2.4 M to 2.4 M (-0.03 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 30.74 | 1,058 | 32,523 | 2,367,178 | 2.4 M to 2.4 M (-0.04 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 30.74 | 1,058 | 32,523 | 2,367,178 | 2.4 M to 2.4 M (-0.04 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 31.28 | 2,068 | 64,687 | 2,368,236 | 2.4 M to 2.4 M (-0.09 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 31.28 | 2,068 | 64,687 | 2,368,236 | 2.4 M to 2.4 M (-0.09 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 30.80 | 3,544 | 109,155 | 2,370,304 | 2.4 M to 2.4 M (-0.15 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 30.80 | 3,544 | 109,155 | 2,370,304 | 2.4 M to 2.4 M (-0.15 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 31.92 | 9,824 | 313,582 | 2,373,848 | 2.4 M to 2.4 M (-0.41 %) |
Jun 07 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 31.92 | 9,824 | 313,582 | 2,373,848 | 2.4 M to 2.4 M (-0.41 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.42 | 130 | 4,215 | 2,383,672 | 2.4 M to 2.4 M (-0.01 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 31.83 | 2,608 | 83,013 | 2,383,802 | 2.4 M to 2.4 M (-0.11 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.50 | 6,671 | 216,808 | 2,386,410 | 2.4 M to 2.4 M (-0.28 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.67 | 7,377 | 241,007 | 2,393,081 | 2.4 M to 2.4 M (-0.31 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.42 | 297 | 9,629 | 4,202,574 | 4.2 M to 4.2 M (-0.01 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 31.83 | 5,918 | 188,370 | 4,202,871 | 4.2 M to 4.2 M (-0.14 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.50 | 15,141 | 492,083 | 4,208,789 | 4.2 M to 4.2 M (-0.36 %) |
Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.67 | 16,742 | 546,961 | 4,223,930 | 4.2 M to 4.2 M (-0.39 %) |
May 27 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.16 | 1,597 | 52,957 | 2,400,458 | 2.4 M to 2.4 M (-0.07 %) |
May 27 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.81 | 1,906 | 62,536 | 2,402,055 | 2.4 M to 2.4 M (-0.08 %) |
May 27 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.01 | 751 | 24,791 | 2,403,961 | 2.4 M to 2.4 M (-0.03 %) |
May 27 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.74 | 9,839 | 322,129 | 2,404,712 | 2.4 M to 2.4 M (-0.41 %) |
May 27 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.59 | 44 | 1,478 | 2,414,551 | 2.4 M to 2.4 M (0.00 %) |
May 27 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 32.87 | 2,852 | 93,745 | 2,414,595 | 2.4 M to 2.4 M (-0.12 %) |
May 24 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.28 | 8,219 | 281,747 | 2,417,447 | 2.4 M to 2.4 M (-0.34 %) |
May 24 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.30 | 1,563 | 52,048 | 2,425,666 | 2.4 M to 2.4 M (-0.06 %) |
May 24 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.80 | 133,359 | 4,640,893 | 2,427,229 | 2.6 M to 2.4 M (-5.21 %) |
May 24 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 34.28 | 18,653 | 639,425 | 4,279,231 | 4.3 M to 4.3 M (-0.43 %) |
May 24 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 33.30 | 3,547 | 118,115 | 4,297,884 | 4.3 M to 4.3 M (-0.08 %) |
May 24 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 34.80 | 302,669 | 10,532,881 | 4,301,431 | 4.6 M to 4.3 M (-6.57 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 35.19 | 600 | 21,114 | 4,604,100 | 4.6 M to 4.6 M (-0.01 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 34.66 | 9,357 | 324,314 | 4,604,700 | 4.6 M to 4.6 M (-0.20 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 35.00 | 4,400 | 154,000 | 4,614,057 | 4.6 M to 4.6 M (-0.10 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 34.23 | 9,143 | 312,965 | 4,618,457 | 4.6 M to 4.6 M (-0.20 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | J | 0.00 | 21,834 | 0 | 4,627,600 | 4.6 M to 4.6 M (-0.47 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 35.14 | 90 | 3,163 | 4,649,434 | 4.6 M to 4.6 M (0.00 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 34.61 | 8,541 | 295,604 | 4,649,524 | 4.7 M to 4.6 M (-0.18 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 33.90 | 14,773 | 500,805 | 4,658,065 | 4.7 M to 4.7 M (-0.32 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 35.19 | 265 | 9,325 | 2,560,588 | 2.6 M to 2.6 M (-0.01 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.66 | 4,122 | 142,869 | 2,560,853 | 2.6 M to 2.6 M (-0.16 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 35.00 | 1,939 | 67,865 | 2,564,975 | 2.6 M to 2.6 M (-0.08 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.23 | 4,029 | 137,913 | 2,566,914 | 2.6 M to 2.6 M (-0.16 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | J | 0.00 | 21,834 | 0 | 2,570,943 | 2.6 M to 2.6 M (-0.84 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 35.14 | 40 | 1,406 | 2,592,777 | 2.6 M to 2.6 M (0.00 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 34.61 | 3,763 | 130,237 | 2,592,817 | 2.6 M to 2.6 M (-0.14 %) |
May 20 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 33.90 | 6,509 | 220,655 | 2,596,580 | 2.6 M to 2.6 M (-0.25 %) |
May 14 2021 | RPTX | Repare Therapeutic ... | Bonita David P | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | Kulkarni Samarth | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | Morrison Briggs | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | Morrison Briggs | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | RHOADS ANN D | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | SCHAFER CAROL | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 14 2021 | RPTX | Repare Therapeutic ... | SCHAFER CAROL | Director | Option Exercise | A | 32.44 | 21,000 | 681,240 | 21,000 | |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 3,473 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 3,473 | 0 | 3,473 | 0 to 3.5 K |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 16,079 | 0 | 144,879 | 161 K to 144.9 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 48,528 | 0 | 0 | 48.5 K to 0 (-100.00 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,520 | 0 | 48,528 | 47 K to 48.5 K (+3.23 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 7,035 | 0 | 63,387 | 70.4 K to 63.4 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 1,373 | 0 | 47,008 | 45.6 K to 47 K (+3.01 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 6,355 | 0 | 57,264 | 63.6 K to 57.3 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 45,635 | 0 | 45,635 | 0 to 45.6 K |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 211,277 | 0 | 1,903,670 | 2.1 M to 1.9 M (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 3,473 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 3,473 | 0 | 3,473 | 0 to 3.5 K |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 16,079 | 0 | 144,879 | 161 K to 144.9 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 48,528 | 0 | 0 | 48.5 K to 0 (-100.00 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 1,520 | 0 | 48,528 | 47 K to 48.5 K (+3.23 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 7,035 | 0 | 63,387 | 70.4 K to 63.4 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 1,373 | 0 | 47,008 | 45.6 K to 47 K (+3.01 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 6,355 | 0 | 57,264 | 63.6 K to 57.3 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 45,635 | 0 | 45,635 | 0 to 45.6 K |
May 07 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 211,277 | 0 | 1,903,670 | 2.1 M to 1.9 M (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 912 | 0 | 11,748 | 10.8 K to 11.7 K (+8.42 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 3,473 | 0 | 0 | 3.5 K to 0 (-100.00 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 3,473 | 0 | 3,473 | 0 to 3.5 K |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 16,079 | 0 | 144,879 | 161 K to 144.9 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,930 | 0 | 10,836 | 8.9 K to 10.8 K (+21.67 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 48,528 | 0 | 0 | 48.5 K to 0 (-100.00 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,520 | 0 | 48,528 | 47 K to 48.5 K (+3.23 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 7,035 | 0 | 63,387 | 70.4 K to 63.4 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 1,373 | 0 | 47,008 | 45.6 K to 47 K (+3.01 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 6,355 | 0 | 57,264 | 63.6 K to 57.3 K (-9.99 %) |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 45,635 | 0 | 45,635 | 0 to 45.6 K |
May 07 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 211,277 | 0 | 1,903,670 | 2.1 M to 1.9 M (-9.99 %) |
Apr 19 2021 | RPTX | Repare Therapeutic ... | Segal Lloyd Mitchell | President and CEO | Sell | S | 35.01 | 5,512 | 192,975 | 142,954 | 148.5 K to 143 K (-3.71 %) |
Mar 15 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | J | 0.00 | 24,271 | 0 | 2,603,089 | 2.6 M to 2.6 M (-0.92 %) |
Mar 15 2021 | RPTX | Repare Therapeutic ... | Foley Todd | Director | Sell | S | 28.18 | 376,412 | 10,607,290 | 2,627,360 | 3 M to 2.6 M (-12.53 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 458,282 | 508.3 K to 458.3 K (-9.84 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 5,176 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 5,176 | 0 | 5,176 | 0 to 5.2 K |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 6,000 | 0 | 0 | 6 K to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Buy | J | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Vantage I, L.P. | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 2,594,451 | 2.9 M to 2.6 M (-10.36 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 6 | 0 | 8,906 | 8.9 K to 8.9 K (+0.07 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 50,000 | 0 | 458,282 | 508.3 K to 458.3 K (-9.84 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 5,176 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 5,176 | 0 | 5,176 | 0 to 5.2 K |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 824 | 0 | 8,900 | 8.1 K to 8.9 K (+10.20 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 6,000 | 0 | 0 | 6 K to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Buy | J | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Jerel Davis | Director | Sell | J | 0.00 | 300,000 | 0 | 2,594,451 | 2.9 M to 2.6 M (-10.36 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 458,282 | 508.3 K to 458.3 K (-9.84 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 5,176 | 0 | 0 | 5.2 K to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 5,176 | 0 | 5,176 | 0 to 5.2 K |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 6,000 | 0 | 0 | 6 K to 0 (-100.00 %) |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
Feb 18 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 300,000 | 0 | 2,594,451 | 2.9 M to 2.6 M (-10.36 %) |
Feb 10 2021 | RPTX | Repare Therapeutic ... | Forte Steve | EVP, Chief Financia ... | Option Exercise | A | 36.91 | 71,000 | 2,620,610 | 71,000 | |
Feb 10 2021 | RPTX | Repare Therapeutic ... | Koehler Maria | EVP, Chief Medical ... | Option Exercise | A | 36.91 | 125,000 | 4,613,750 | 125,000 | |
Feb 10 2021 | RPTX | Repare Therapeutic ... | Zinda Michael | EVP, Chief Science ... | Option Exercise | A | 36.91 | 125,000 | 4,613,750 | 125,000 | |
Feb 10 2021 | RPTX | Repare Therapeutic ... | Segal Lloyd Mitchell | President and CEO | Option Exercise | A | 36.91 | 125,000 | 4,613,750 | 125,000 | |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 745 | 0 | 0 | 745 to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 745 | 0 | 745 | 0 to 745 |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 751 | 0 | 0 | 751 to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 751 | 0 | 751 | 0 to 751 |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 50,000 | 0 | 508,282 | 558.3 K to 508.3 K (-8.96 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 4,313 | 0 | 0 | 4.3 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 4,313 | 0 | 4,313 | 0 to 4.3 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Buy | J | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Feb 02 2021 | RPTX | Repare Therapeutic ... | Versant Ventures V, LLC | 10% Owner | Sell | J | 0.00 | 250,000 | 0 | 2,894,451 | 3.1 M to 2.9 M (-7.95 %) |